The trend of the over-emphasis on having the results of a research work to be statistically significant (P\<.05) is still going strong today due to the fact most researchers are statistically-phobiaed. In this write-up, I want to encourage a research paper reader to firstly critique on the research process. [Table 1](#t1-0030161){ref-type="table"} shows the stages of a research study that need to be addressed in detail before a credible and clinically relevant result could be obtained.

It is essential that stages 1 & 2 be properly set-up (available, hopefully, in the Materials & Methods of a paper) otherwise, even with the help of a statistician the results obtained will not be valid!

For the results, the important question to ask is "Is the work clinically relevant to me?" An important point for a P-value worshipper to take note: "P-value is influenced by sample size, the larger the sample size, the likelihood of P\<.05 is increased!". For example, a researcher wants to determine the correlation between airway volume & lower face height; [Table 2a](#t2a-0030161){ref-type="table"} shows a relatively poor correlation of r=0.271, P=0.100 with n=38. But when n was doubled, though the relationship remains poor, the P-value has become significant (P=0.018), see [Table 2b](#t2b-0030161){ref-type="table"} -- the impact of sample size! [Figure 1](#f1-0030161){ref-type="fig"} shows the graphical presentation of the poor relationship. A good clinical relationship (say between lower face height and anterior face height, r=0.827) will be given by r\>0.7 ([Figure 2](#f2-0030161){ref-type="fig"}).

In a correlation analysis, both variables are taken to be dependent. If we want to use lower face height to predict airway volume, the squaring of the correlation (r=0.217) shows that lower face height only explains about 5% of the variation in airway volume; whereas lower face height will explain 68% (squaring 0.827) of the variance in anterior face height. We will need the adjusted r-square of a multiple linear regression model to be high (at least 0.8) if we want to use the model for the prediction of the outcome variable. But if one is interested to determine significant predictors on the outcome variable, then the value of the adjusted r-square is not crucial in the interpretation anymore; since the interest is on the individual-predictor's P-value.

[Table 3](#t3-0030161){ref-type="table"} shows the 4 combinations a research study can have on their clinical and statistical significances.

You are right! The "Clinical significance" should be focused first then the p-value. Scenarios 1 and 3 will be published but scenario 2 will miss a potential intervention as the possibility of getting a publication will be low because of P\>.05!

For the statistically-phobiaed, [Table 4](#t4-0030161){ref-type="table"} gives a summary of the various statistical techniques (the detailed discussions are given in references [@b3-0030161]--[@b9-0030161]) that have a coverage of about 75--80% of all analyses performed in published articles; otherwise you may want to refer to the references [@b10-0030161]--[@b18-0030161] or alternatively seek a consult from a statistician.

In conclusion, statistics is akin to a oven in a cake-baking process; an essential apparatus but the quality of the cake predominantly depends on the baker (the researcher) and the quality of the ingredients (data quality), though the brand of the oven does enhance a better cake-quality. It is strongly encouraged to get a statistician involved in the planning stage of your study to assist in the Stages 1 & 2 of the research process before finally setting up the database and statistical analysis. Are you still a p-value worshipper? I wish - no more, hurray!
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###### 

Stages of a research process.[@b1-0030161]

  Stages                                                     Percentage of contribution to validity of clinical results obtained
  ---------------------------------------------------------- ---------------------------------------------------------------------
  Stage 1                                                    
  Proper study design                                        
  (Epidemiological/Randomized Controlled Trial)              30 -- 40%
  Sample size calculations[@b2-0030161]                      
  (Precision/Power calculations)                             
  Stage 2                                                    
  Conduct of study/Data integrity (Garbage in Garbage out)   50 -- 60%
  Stage 3                                                    
  Proper database setup/Statistics                           10 -- 20%

###### 

Correlation with n=38.

  Correlations                                     
  ------------------- --------------------- ------ ------
  Airway volume       Pearson correlation   1      .271
                      Sig. (2-tailed)              .1
                      N                     38     38
  Lower face height   Pearson correlation   .271   1
                      Sig. (2-tailed)       .1     
                      N                     38     38

###### 

Correlation with n=76.

  Correlations                                                                             
  ------------------- --------------------- ---------------------------------------------- ----------------------------------------------
  Airway volume       Pearson correlation   1                                              .271[\*](#tfn1-0030161){ref-type="table-fn"}
                      Sig. (2-tailed)                                                      .018
                      N                     76                                             76
  Lower face height   Pearson correlation   .271[\*](#tfn1-0030161){ref-type="table-fn"}   1
                      Sig. (2-tailed)       .018                                           
                      N                     76                                             76

Correlation is significant at the .05 level (2-tailed).

###### 

Clinical vs statistical significance.

  Clinical significance achieved?   Statistical significance achieved?   Implications of study results
  --------------------------------- ------------------------------------ -----------------------------------------------------------------------------------
  Yes                               Yes                                  Reproducible valuable study
  Yes                               No                                   Potential trend but could be due to chance (Pilot study)
  No                                Yes                                  Large sample size -- still good information on 'best' clinical efficacy achieved.
  No                                No                                   Forget about it!

###### 

Summary of statistical techniques.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Quantitative data                                                                                                                                                       
  ------------------------------------------------------------------------------------------------------------- --------------------------------------------------------- ------------------------------------------------------------------------------------------------
  **Normality assumed (Parametric)**                                                                            **Normality not assumed (Non-parametric)**                

                                                                                                                                                                          

  1 Sample T (e.g. Weight of today's infants compared to the reference-norm 5 years ago)                        Wilcoxon Signed Rank                                      

  Paired T (e.g. Pre-Post intervention weight loss)                                                                                                                       

                                                                                                                                                                          

  **Homogenity (Equal variance) assumed**                                                                       N-way Anova (All independent variables are categorical)   

                                                                                                                                                                          

  Yes                                                                                                           No                                                        Linear regression (All independent variables are quantitative)

  2 Sample T (e.g. Differences in SBP between gender)                                                           Mann Whitney U\                                           ANCOVA: Analysis of covariance (mixture of categorical and quantitative independent variables)
                                                                                                                Wilcoxon Rank Sum                                         

  One-way Anova (e.g. Differences in SBP amongst BMI groups -- underweight, normal weight, overweight, obese)   Kruskal Wallis                                            

  Pearson's Correlation (e.g. Association between SBP and age)                                                  Spearman's Correlation                                    

                                                                                                                                                                          

  **Qualitative data**                                                                                                                                                    

  Test of associations (e.g. Smoking with cancer)\                                                              Chi-square (large n)\                                     Logistic regression
  Strength of associations                                                                                      Fisher's exact (small n)\                                 
                                                                                                                Relative risk (prospective outcomes)\                     
                                                                                                                Odds ratios (non-prospective outcomes)                    

  Matched case-control\                                                                                         McNemar                                                   Conditional logistic regression
  Pre-Post qualitative outcomes                                                                                                                                           

                                                                                                                                                                          

  **Time to event data (Survival analysis)**                                                                                                                              

  Kaplan Meier                                                                                                  Cox regression                                            
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
